These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20684670)

  • 1. Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%.
    Kirson NY; Ivanova JI; Birnbaum HG; Wei R; Kantor E; Amy Puenpatom R; Ben-Joseph RH; Summers KH
    J Med Econ; 2010; 13(3):472-81. PubMed ID: 20684670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
    Kirson NY; Ivanova JI; Birnbaum HG; Wei R; Kantor E; Puenpatom RA; Ben-Joseph RH; Summers KH
    J Med Econ; 2010; 13(3):482-91. PubMed ID: 20684669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
    Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
    Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine patch for treatment of postherpetic neuralgia?
    Alper BS; Lewis PR
    Am Fam Physician; 2006 Aug; 74(3):378; author reply 381. PubMed ID: 16913155
    [No Abstract]   [Full Text] [Related]  

  • 5. ZTlido--a new lidocaine patch for postherpetic neuralgia.
    Med Lett Drugs Ther; 2019 Mar; 61(1568):41-43. PubMed ID: 31022155
    [No Abstract]   [Full Text] [Related]  

  • 6. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia.
    Kanai A; Okamoto T; Suzuki K; Niki Y; Okamoto H
    Anesth Analg; 2010 May; 110(5):1457-60. PubMed ID: 20237042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lidocaine plasters for postherpetic neuralgia?
    BMJ Group
    Drug Ther Bull; 2008 Feb; 46(2):14-6. PubMed ID: 18256177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
    Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
    Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
    Binder A; Rogers P; Hans G; Baron R
    Pain Manag; 2016; 6(3):229-39. PubMed ID: 26821240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of percutaneous lidocaine administration and xenon-ray irradiation on post-herpetic neuralgia in liver transplant recipients: a report of three cases].
    Mochizuki N; Ide S; Shibata J; Hasegawa J; Tanaka S; Ikeno S; Kitoh T; Kawamata M
    Masui; 2009 Jan; 58(1):92-5. PubMed ID: 19175022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5% lidocaine medicated plasters vs. sympathetic nerve blocks as a part of multimodal treatment strategy for the management of postherpetic neuralgia: a retrospective, consecutive, case-series study.
    Malec-Milewska M; Horosz B; Sękowska A; Kolęda I; Kucia H; Kosson D
    Neurol Neurochir Pol; 2015; 49(1):24-8. PubMed ID: 25666769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine.
    Hayashida M; Fukuda K; Fukunaga A; Meno A; Sato K; Tarui K; Arita H; Kaneko Y; Hanaoka K
    J Anesth; 2005; 19(1):31-5. PubMed ID: 15674513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia.
    Amjad M; Mashhood AA
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):683-5. PubMed ID: 16300701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.
    Geha PY; Baliki MN; Chialvo DR; Harden RN; Paice JA; Apkarian AV
    Pain; 2007 Mar; 128(1-2):88-100. PubMed ID: 17067740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Topical lidocaine for the treatment of postherpetic neuralgia.
    Khaliq W; Alam S; Puri NK
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004846. PubMed ID: 24166584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care expenditure burden of persisting herpes zoster pain.
    Dworkin RH; White R; O'Connor AB; Hawkins K
    Pain Med; 2008 Apr; 9(3):348-53. PubMed ID: 18366512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Irving GA; Backonja MM; Dunteman E; Blonsky ER; Vanhove GF; Lu SP; Tobias J;
    Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.